1. Home
  2. ARDX vs DHC Comparison

ARDX vs DHC Comparison

Compare ARDX & DHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • DHC
  • Stock Information
  • Founded
  • ARDX 2007
  • DHC 1998
  • Country
  • ARDX United States
  • DHC United States
  • Employees
  • ARDX N/A
  • DHC N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • DHC Real Estate Investment Trusts
  • Sector
  • ARDX Health Care
  • DHC Real Estate
  • Exchange
  • ARDX Nasdaq
  • DHC Nasdaq
  • Market Cap
  • ARDX 885.2M
  • DHC 757.5M
  • IPO Year
  • ARDX 2014
  • DHC N/A
  • Fundamental
  • Price
  • ARDX $3.93
  • DHC $3.76
  • Analyst Decision
  • ARDX Strong Buy
  • DHC Hold
  • Analyst Count
  • ARDX 9
  • DHC 3
  • Target Price
  • ARDX $10.17
  • DHC $4.50
  • AVG Volume (30 Days)
  • ARDX 4.6M
  • DHC 900.6K
  • Earning Date
  • ARDX 07-31-2025
  • DHC 07-31-2025
  • Dividend Yield
  • ARDX N/A
  • DHC 1.07%
  • EPS Growth
  • ARDX N/A
  • DHC N/A
  • EPS
  • ARDX N/A
  • DHC N/A
  • Revenue
  • ARDX $361,706,000.00
  • DHC $1,511,515,000.00
  • Revenue This Year
  • ARDX $12.01
  • DHC $3.98
  • Revenue Next Year
  • ARDX $34.66
  • DHC $4.50
  • P/E Ratio
  • ARDX N/A
  • DHC N/A
  • Revenue Growth
  • ARDX 127.33
  • DHC 5.33
  • 52 Week Low
  • ARDX $3.21
  • DHC $2.00
  • 52 Week High
  • ARDX $8.06
  • DHC $4.24
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 57.99
  • DHC 64.23
  • Support Level
  • ARDX $3.49
  • DHC $3.50
  • Resistance Level
  • ARDX $3.72
  • DHC $3.64
  • Average True Range (ATR)
  • ARDX 0.16
  • DHC 0.15
  • MACD
  • ARDX 0.06
  • DHC -0.02
  • Stochastic Oscillator
  • ARDX 98.21
  • DHC 50.88

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About DHC Diversified Healthcare Trust of Beneficial Interest

Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs. Majority of revenue is from SHOP segment.

Share on Social Networks: